MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients

Cancer Biology and Therapy

Volumn 8, Issue 11, 2009, Pages 996-999

  Pantano, Francesco ^a   Baldi, Alfonso ^b   Santini, Daniele ^a   Vincenzi, Bruno ^a   Borzomati, Domenico ^a   Vecchio, Fabio Maria ^c   Castri, Federica ^c   Antinori, Armando ^c   Caraglia, Michele ^b   Magistrelli, Paolo ^c   Coppola, Roberto ^a   Tonini, Giuseppe ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Adenocarcinoma; MUC2; MUC5; Mucins; Pancreatic ductal; Prognosis

Indexed keywords

MUCIN; MUCIN 2; MUCIN 5; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MUCIN-2; MUCIN-5B; PANCREATIC NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 68049129825     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.11.8537     Document Type: Article

References (28)

1. Dekker J, Rossen JWA, Buller HA, Einerhand AWC. The MUC family: an obituary. Trends Biochem Sci 2002; 27:126-31.
2. Corrales RM, Galarreta DJ, Herreras JM, Calonge M, Chaves FJ. Normal human conjunctival epithelium expresses MUC13, MUC15, MUC16 and MUC17 mucin genes. Arch Soc Esp Oftalmol 2003; 78:375-81.
3. Gum JR Jr, Crawley SC, Hicks JW, Szymkowski DE, Kim YS. MUC17, a novel membrane-tethered mucin. Biochem Biophys Res Commun 2003; 291:466-75.
4. Gendler SJ. MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia 2001; 6:339-53.
5. Taylor-Papadimitriou J, Burchell JM, Plunkett T, et al. MUC1 and the immunobiology of cancer. J Mammary Gland Biol Neoplasia 2002; 7:209-21.
6. Ringel J, Lohr M. The MUC gene family: their role in diagnosis and early detection of pancreatic cancer. Mol Cancer 2003; 2:9.
7. Allen A, Hutton DA, Pearson JP. The MUC2 gene product: a human intestinal mucin. Int J Biochem Cell Biol 1998; 30:797-801.
8. Van Klinken BJ, Tytgat KM, Buller HA, Einerhand AW, Dekker J. Biosynthesis of intestinal mucins: MUC1, MUC2, MUC3 and more. Biochem Soc Trans 1995; 23:814-8.
9. Kim YS, Gum JR Jr, Byrd JC, Toribara NW. The structure of human intestinal apomucins. Am Rev Respir Dis 1991; 144:10-4.
10. Yonezawa S, Sato E. Expression of mucin antigens in human cancers and its relationship with malignancy potential. Pathol Int 1997; 47:813-30.
11. Van De Bovenkamp JH, Korteland-Van Male AM, Warson C, Büller HA, Einerhand AW, Ectors NL. Gastric-type mucin and TFF-peptide expression in Barrett's oesophagus is disturbed during increased expression of MUC2. Histopathology 2003; 42:555-65.
12. Warson C, Van De Bovenkamp JH, Korteland-Van Male AM, Büller HA, Einerhand AW, Ectors NL. Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. Hum Pathol 2002; 33:660-8.
13. Ho SB, Roberton AM, Shekels LL, Lyftogt CT, Niehans GA, Tribara NW. Expression cloning of gastric mucin complementary DNA and localization of mucin gene expression. Gastroenterology 1995; 49:735-47.
14. Bolos C, Garrido M, Real FX. MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. Gastroenterology 1995; 49:723-34.
15. Terada T, Ohta T, Sasaki M, Nakanuma Y, Kim YS. Expression of MUC apomucins in normal pancreas and pancreatic tumors. J Pathol 1996; 180:160-5.
16. Kim GE, Bae HI, Park HU, Kuan SF, Crawley SC, Ho JJ, et al. Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. Gastroenterology 2002; 123:1052-60.
17. Luttges J, Zamboni G, Longnecker D, Kloppel G. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol 2001; 25:942-8.
18. Chhieng DC, Benson E, Eltoum I, Eloubeidi MA, Jhala N, Jhala D, et al. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration. Cancer 2003; 99:365-71.
19. Lüttges J, Zamboni G, Longnecker D, Klöppel G. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol 2001; 25:942-8.
20. Yonezawa S, Taira M, Osako M, Kubo M, Tanaka S, Sakoda K, et al. MUC-1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas. Pathol Int 1998; 48:319-22.
21. Kim YS. Diversity of mucin genes, structure, function and expression. Gastroenterology 1995; 49:999-1013.
22. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-81.
23. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35:1-39.
24. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37:4-66.
25. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003; 53:5.
26. Sener S, Frengen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 1999; 189:1.
27. Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S, et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 2002; 295:1726-9.
28. Siedow A, Szyf M, Gratchev A, Kobalz U, Hanski ML, Bumke-Vogt C, et al. De novo expression of the Muc2 gene in pancreas carcinoma cells is triggered by promoter demethylation. Tumor Biol 2002; 23:54-60.